Developer docs
API playgroundTry for free, no card

Search company profiles

Globion

Full company profile

uuid002mxrl

Namestring
Globion
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Globion is an India-based animal health company founded in 2006, headquartered in Secunderabad, with a workforce of 101-250 employees. The company engages in the production of vaccines for animals, operating within the broader pet and animal health sector — an addressable market context where global pet care is valued at approximately $246.7 billion (2023), projected to reach $427.8 billion by 2032.

Specific product details, manufacturing technology, and pricing models are not publicly disclosed in available sources. The company serves the veterinary and animal husbandry value chain in India, producing biologics (vaccines) that address health needs across livestock and companion animal segments. Its customer segmentation is vertical, focused on the pet and animal health use case.

Globion operates as a majority-owned subsidiary of Virbac, a global animal health company. Virbac acquired its majority stake as part of a stated strategy to strengthen its position in the Asia-Pacific region, specifically targeting expansion in the pet health market including Japan. The company's executive leadership is led by CEO Dibyendu Dey. Revenue, financial performance, and detailed product portfolio data are not disclosed in available source material.

Short descriptiontext

Globion is an India-based animal health company founded in 2006 that manufactures vaccines for animals. It operates within the pet and animal health sector and is a majority-owned subsidiary of Virbac, supporting Asia-Pacific expansion.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSecunderabad, India
HQ citystring
Secunderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal vaccines, veterinary biologicals, pet health products, livestock vaccines, animal healthcare
Industry2 codes
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAKAB
Livestock Vaccines (Cattle, Swine, Sheep & Goats)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Animal Vaccines
Cost components3 values
Supply Chain, Operations, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Globion is an Indian animal health company that produces vaccines for animals, serving the pet care and veterinary health sectors. The company manufactures biological products used in veterinary applications and operates within the broader animal health industry.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Globion is an Indian pet and animal health company in which Virbac acquired a majority stake to strengthen its presence in the Asia-Pacific region. The specific products and services offered by Globion are not detailed in the available sources.

Product and service1 record
1Animal Vaccines
CategoryVeterinary Biologicals
Description

Biological vaccine products manufactured for use in animals, serving veterinary, livestock, and pet health applications. Targeted at veterinary professionals, livestock farmers, and animal health distributors.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Virbac is Globion's parent company and the world's seventh-largest animal health player, with a comprehensive portfolio of veterinary vaccines, pharmaceuticals, and diagnostics. Directly comparable as a veterinary vaccine manufacturer and the strategic anchor for Globion's APAC expansion.

TypeBroad incumbent
Description

Elanco is a major global animal health company with significant livestock and companion animal vaccine offerings, particularly in poultry and cattle. Comparable as a multinational vaccine competitor expanding into emerging markets where Globion operates.

TypeDirect peer
Description

Indian Immunologicals is a leading Hyderabad-based manufacturer of veterinary and human vaccines, including livestock vaccines for foot-and-mouth disease and rabies. Highly comparable as a domestic Indian animal vaccine producer competing in the same end-markets and regulatory framework as Globion.

TypeDirect peer
Description

Hester Biosciences is an Indian veterinary biologicals and animal health products company focused on poultry and livestock vaccines. Directly comparable in scale and product category, serving the same Indian livestock producer base with similar vaccine technologies.

TypeBroad incumbent
Description

Ceva is a global veterinary pharmaceutical and vaccine company with strong poultry and swine vaccine franchises and an active APAC growth strategy. Comparable as a multinational vaccine incumbent competing for emerging-market share with Globion.

TypeBroad incumbent
Description

Zoetis is the world's largest animal health company and a leading producer of livestock and companion animal vaccines globally. Comparable as a broad veterinary vaccine incumbent that competes with Globion for share in India and other APAC markets.

TypeEmerging player
Description

Phibro Animal Health is a US-listed animal health company with a focus on livestock vaccines, nutrition, and pharmaceuticals. Comparable in product category, particularly in cattle and poultry vaccines that overlap with Globion's likely livestock portfolio.

TypeDirect peer
Description

Biovet is an Indian manufacturer of veterinary vaccines and biologicals with a focus on livestock and poultry. Comparable as a domestic Indian vaccine producer competing for the same customer base and tender contracts as Globion.

9Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Boehringer Ingelheim's animal health division is one of the top global vaccine manufacturers for swine, poultry, and companion animals. Comparable as a global veterinary biologics incumbent expanding its presence in APAC and competing for institutional/government tenders that Globion also targets.

TypeBroad incumbent
Description

Merck Animal Health (MSD Animal Health outside the US) is a leading global manufacturer of livestock and companion animal vaccines. Comparable as a broad incumbent with significant APAC ambitions and overlapping vaccine portfolios in cattle, swine, and poultry segments.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Globion

Animal Vaccinesglobionindia.com

Globion is an India-based animal health company founded in 2006 that manufactures vaccines for animals. It operates within the pet and animal health sector and is a majority-owned subsidiary of Virbac, supporting Asia-Pacific expansion.

What Globion does

Globion is an India-based animal health company founded in 2006, headquartered in Secunderabad, with a workforce of 101-250 employees. The company engages in the production of vaccines for animals, operating within the broader pet and animal health sector — an addressable market context where global pet care is valued at approximately $246.7 billion (2023), projected to reach $427.8 billion by 2032.

Specific product details, manufacturing technology, and pricing models are not publicly disclosed in available sources. The company serves the veterinary and animal husbandry value chain in India, producing biologics (vaccines) that address health needs across livestock and companion animal segments. Its customer segmentation is vertical, focused on the pet and animal health use case.

Globion operates as a majority-owned subsidiary of Virbac, a global animal health company. Virbac acquired its majority stake as part of a stated strategy to strengthen its position in the Asia-Pacific region, specifically targeting expansion in the pet health market including Japan. The company's executive leadership is led by CEO Dibyendu Dey. Revenue, financial performance, and detailed product portfolio data are not disclosed in available source material.

Globion firmographics

Firmographics
Name
Globion
Website
https://globionindia.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
Globion is an India-based animal health company founded in 2006 that manufactures vaccines for animals. It operates within the pet and animal health sector and is a majority-owned subsidiary of Virbac, supporting Asia-Pacific expansion.
Ownership category
akta.pro rank

Globion industry classification

Industry
Product category
Animal Vaccines
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAKAB
Livestock Vaccines (Cattle, Swine, Sheep & Goats)

Keywords

  • Animal vaccines
  • Veterinary biologicals
  • Pet health products
  • Livestock vaccines
  • Animal healthcare

Where Globion is headquartered

Location

Headquarters

HQ city
Secunderabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Globion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel

Globion product offering

Product offering

Core offering

Globion is an Indian animal health company that produces vaccines for animals, serving the pet care and veterinary health sectors. The company manufactures biological products used in veterinary applications and operates within the broader animal health industry.

Product overview

Globion is an Indian pet and animal health company in which Virbac acquired a majority stake to strengthen its presence in the Asia-Pacific region. The specific products and services offered by Globion are not detailed in the available sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • Animal Vaccines Biological vaccine products manufactured for use in animals, serving veterinary, livestock, and pet health applications. Targeted at veterinary professionals, livestock farmers, and animal health distributors.

Companies that use Globion

Customer profile

Segments1 record

Ideal customer profiles1 record

Globion technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Globion partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Globion competitors and assessment

Company assessment

Broad incumbents

  • Virbac: Virbac is Globion's parent company and the world's seventh-largest animal health player, with a comprehensive portfolio of veterinary vaccines, pharmaceuticals, and diagnostics. Directly comparable as a veterinary vaccine manufacturer and the strategic anchor for Globion's APAC expansion.
  • Elanco Animal Health: Elanco is a major global animal health company with significant livestock and companion animal vaccine offerings, particularly in poultry and cattle. Comparable as a multinational vaccine competitor expanding into emerging markets where Globion operates.
  • Ceva Santé Animale: Ceva is a global veterinary pharmaceutical and vaccine company with strong poultry and swine vaccine franchises and an active APAC growth strategy. Comparable as a multinational vaccine incumbent competing for emerging-market share with Globion.
  • Zoetis: Zoetis is the world's largest animal health company and a leading producer of livestock and companion animal vaccines globally. Comparable as a broad veterinary vaccine incumbent that competes with Globion for share in India and other APAC markets.
  • Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health division is one of the top global vaccine manufacturers for swine, poultry, and companion animals. Comparable as a global veterinary biologics incumbent expanding its presence in APAC and competing for institutional/government tenders that Globion also targets.
  • Merck Animal Health: Merck Animal Health (MSD Animal Health outside the US) is a leading global manufacturer of livestock and companion animal vaccines. Comparable as a broad incumbent with significant APAC ambitions and overlapping vaccine portfolios in cattle, swine, and poultry segments.

Direct peers

  • Indian Immunologicals: Indian Immunologicals is a leading Hyderabad-based manufacturer of veterinary and human vaccines, including livestock vaccines for foot-and-mouth disease and rabies. Highly comparable as a domestic Indian animal vaccine producer competing in the same end-markets and regulatory framework as Globion.
  • Hester Biosciences: Hester Biosciences is an Indian veterinary biologicals and animal health products company focused on poultry and livestock vaccines. Directly comparable in scale and product category, serving the same Indian livestock producer base with similar vaccine technologies.
  • Biovet Private Limited: Biovet is an Indian manufacturer of veterinary vaccines and biologicals with a focus on livestock and poultry. Comparable as a domestic Indian vaccine producer competing for the same customer base and tender contracts as Globion.

Emerging players

  • Phibro Animal Health: Phibro Animal Health is a US-listed animal health company with a focus on livestock vaccines, nutrition, and pharmaceuticals. Comparable in product category, particularly in cattle and poultry vaccines that overlap with Globion's likely livestock portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Globion social profiles

Digital presence

Globion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Globion leadership team

Management profile

Number of profiles

Profiles1 record

Globion funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Globion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Globion

What does Globion do?

Globion is an Indian animal health company that produces vaccines for animals, serving the pet care and veterinary health sectors. The company manufactures biological products used in veterinary applications and operates within the broader animal health industry.

Is Globion a public or private company?

Globion is a private company. It is classified as corporate owned and is currently operating.

When was Globion founded?

Globion was founded in 2006. It employs 101 to 250 people.

Where is Globion based?

Globion is headquartered in Secunderabad, India, in the Asia region.

Who are Globion's main competitors?

Broad incumbents on record are Virbac, Elanco Animal Health, Ceva Santé Animale, Zoetis, Boehringer Ingelheim Animal Health and Merck Animal Health. Direct peers are Indian Immunologicals, Hester Biosciences and Biovet Private Limited. Phibro Animal Health is listed as an emerging player.

Does Globion have an API?

No public API is recorded for Globion.

What industry is Globion in?

Globion's product category is Animal Vaccines. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals